Radiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood Cancer -
MM Hawkins, LMK Wilson, HS Burton, MHN Potok, DL … - jnci, 1996 - jnci.oxfordjournals.org
... 88, No. 5, 270-278, March 6, 1996 ? 1996 Oxford University Press Radiotherapy,
Alkylating Agents, and Risk of Bone Cancer After Childhood Cancer. ...
Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain -
MJ Schwei, P Honore, SD Rogers, JL Salak-Johnson, … - J Neurosci, 1999 - Soc Neuroscience
... 10886-10897. Neurochemical and Cellular Reorganization of the Spinal Cord
in a Murine Model of Bone Cancer Pain. Matthew J. Schwei ...
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double- … -
AN Serafini, SJ Houston, I Resche, DP Quick, FM … - Journal of Clinical Oncology, 1998 - jcojournal.org
... ARTICLES. Palliation of pain associated with metastatic bone cancer using
samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. ...
… -Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer -
S Braun, K Pantel, P Muller, W Janni, F Hepp, CRM … - New England Journal of Medicine, 2000 - content.nejm.org
... The Prognostic Value of Isolated Tumor Cells in Bone Marrow in Breast Cancer Patients:
Evaluation of Morphological Categories and the Number of Clinically ...
Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related … -
P Honore, NM Luger, MAC Sabino, MJ Schwei, SD … - Nature Medicine, 2000 - nature.com
... Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and
pain-related neurochemical reorganization of the spinal cord. ...
Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in … -
IJ Diel, M Kaufmann, SD Costa, R Holle, G von … - jnci, 1996 - jnci.oxfordjournals.org
... Press Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery:
Prognostic Value in Comparison With Nodal Status. Ingo ...
A survey of telomerase activity in human cancer -
JW Shay, S Bacchetti - European Journal of Cancer, 1997 - Elsevier
... tumor of bone. Cancer 1995, 75, 109441099. Butler MG, Dahir GA, Hedges LK,
Julia0 SF, Sciadini MF, Schwartz HS. Cytogenetic, telomere ...
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer -
RR Love, RB Mazess, HS Barden, S Epstein, PA … - The New England Journal of Medicine, 1992 - nejm.org
Effects of tamoxifen on bone mineral density in postmenopausal women with breast
cancer. ... Aromatase Inhibitors and Bone Health in Women With Breast Cancer. ...
… of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone … -
GN Hortobagyi, RL Theriault, L Porter, D Blayney, … - New England Journal of Medicine, 1996 - content.nejm.org
... Background Bisphosphonates such as pamidronate disodium inhibit osteoclast-induced
bone resorption associated with cancer that has metastasized to bone. ...
A multigenic program mediating breast cancer metastasis to bone -
Y Kang, PM Siegel, W Shu, M Drobnjak, SM Kakonen, C … - Cancer Cell, 2003 - Elsevier
... Article. A multigenic program mediating breast cancer metastasis to bone. ... 2002) in
human cancer has been clinically correlated with bone metastasis. ...
Source: Google Scholar |